» Articles » PMID: 22684480

Identifying and Testing Candidate Genetic Polymorphisms in the Irritable Bowel Syndrome (IBS): Association with TNFSF15 and TNFα

Overview
Journal Gut
Specialty Gastroenterology
Date 2012 Jun 12
PMID 22684480
Citations 77
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The postinfectious irritable bowel syndrome (PI-IBS) suggests that impaired resolution of inflammation could cause IBS symptoms. The authors hypothesised that polymorphisms in genes whose expression were altered by gastroenteritis might be linked to IBS with diarrhoea (IBS-D) which closely resembles PI-IBS.

Design: Part 1: 25 healthy volunteers (HVs), 21 patients 6 months after Campylobacter jejuni infection, 37 IBS-D and 19 IBS with constipation (IBS-C) underwent rectal biopsy for gene expression analysis and peripheral blood mononuclear cell cytokine production assessment. Part 2: Polymorphisms in genes whose expression was altered in Part 1 were assessed in 179 HV, 179 IBS-D, 122 IBS-C and 41 PI-IBS.

Results: Part 1: Mucosal expression of seven genes was altered in IBS: CCL11, CCL13, Calpain 8 and TNFSF15 increased while NR1D1, GPR161 and GABRE decreased with similar patterns after infection with C jejuni. Part 2: The authors assessed 21 known single nucleotide polymorphisms (SNPs) in these seven genes and one SNP in each of the TNFα and IL-10 genes. Three out of five TNFSF15 SNPs (rs6478108, rs6478109 and rs7848647) showed reduced minor allele frequency (MAF) (0.28, 0.27 and 0.27) in subjects with IBS-D compared with HV (0.38, 0.36 and 0.37; p=0.007, 0.015 and 0.007, respectively) confirming others recent findings. The authors also replicated the previously reported association of the TNFα SNP rs1800629 with PI-IBS which showed an increase in the MAF at 0.30 versus 0.19 for HV (p=0.04).

Conclusion: IBS-D and PI-IBS patients are associated with TNFSF15 and TNFα genetic polymorphisms which also predispose to Crohn's disease suggesting possible common underlying pathogenesis.

Citing Articles

Rome Foundation Working Team Report on overlap in disorders of gut-brain interaction.

Barbara G, Aziz I, Ballou S, Chang L, Ford A, Fukudo S Nat Rev Gastroenterol Hepatol. 2025; .

PMID: 39870943 DOI: 10.1038/s41575-024-01033-9.


Bowel preparation before colonoscopy: Consequences, mechanisms, and treatment of intestinal dysbiosis.

Zheng Z, Zheng Q, Wang L, Liu Y World J Gastroenterol. 2025; 31(2):100589.

PMID: 39811511 PMC: 11684204. DOI: 10.3748/wjg.v31.i2.100589.


An overlap-weighted analysis on the association of constipation symptoms with disease progression and survival in amyotrophic lateral sclerosis: a nested case-control study.

Niu T, Wang P, Zhou X, Liu T, Liu Q, Li R Ther Adv Neurol Disord. 2025; 18():17562864241309811.

PMID: 39803328 PMC: 11719447. DOI: 10.1177/17562864241309811.


Integrative Multi-Omics Analysis Reveals Critical Molecular Networks Linking Intestinal-System Diseases to Colorectal Cancer Progression.

Ji S, Hu H, Zhu R, Guo D, Liu Y, Yang Y Biomedicines. 2025; 12(12.

PMID: 39767563 PMC: 11673540. DOI: 10.3390/biomedicines12122656.


Unraveling the genetic susceptibility of irritable bowel syndrome: integrative genome-wide analyses in 845 492 individuals: a diagnostic study.

Huang W, Zhang L, Ma Y, Yu S, Lyu Y, Tong S Int J Surg. 2024; 111(1):210-220.

PMID: 39166955 PMC: 11745715. DOI: 10.1097/JS9.0000000000002039.